Implication of HLA-G 3′ untranslated region polymorphisms in human papillomavirus infection

Tissue Antigens

Volumn 83, Issue 2, 2014, Pages 113-118

  Bortolotti, D ^a   Gentili, V ^a   Rotola, A ^a   Di Luca, D ^a   Rizzo, R ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

Human leukocyte antigen G; Human papillomavirus; Invasive cervical cancer

Indexed keywords

DODECYL SULFATE SODIUM; ETHER; HLA G ANTIGEN; INTERLEUKIN 10; NUCLEIC ACID; VIRUS DNA;

3' UNTRANSLATED REGION; ALLELE; ARTICLE; CANCER PATIENT; CONDYLOMA ACUMINATUM; DISEASE ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 39; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 53; HUMAN PAPILLOMAVIRUS TYPE 56; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 59; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN PAPILLOMAVIRUS TYPE 66; HUMAN PAPILLOMAVIRUS TYPE 70; NONHUMAN; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; UTERINE CERVIX CANCER; WART VIRUS;

HUMAN PAPILLOMAVIRUS;

HUMAN LEUKOCYTE ANTIGEN-G; HUMAN PAPILLOMAVIRUS; INVASIVE CERVICAL CANCER;

3' UNTRANSLATED REGIONS; ALLELES; CERVICAL INTRAEPITHELIAL NEOPLASIA; CONDYLOMATA ACUMINATA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HLA-G ANTIGENS; HUMANS; NEOPLASMS, SQUAMOUS CELL; PAPILLOMAVIRUS INFECTIONS; POLYMORPHISM, GENETIC; RISK FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 84892965782     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/tan.12281     Document Type: Article

References (44)

1. Li N, Franceschi S, Howell-Jones R, Snijders PJ, Clifford GM. Human papillomavirus type distribution in 30, 848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication. Int J Cancer 2011: 128: 927-35.
2. Walboomers JM, Jacobs MV, Manos MM et al. Human papillomavirus is a necessary cause of invasive cervical cancer. J Pathol 1999: 189: 12-9.
3. Trottier H, Franco EL. The epidemiology of genital human papillomavirus infection. Vaccine 2006: 24: S1.
4. Grabowska AK, Riemer AB. The invisible enemy - how human papillomaviruses avoid recognition and clearance by the host immune system. Open Virol J 2012: 6: 249-56.
5. Bolpetti A, Silva JS, Villa LL, Lepique AP. Interleukin-10 production by tumor infiltrating macrophages plays a role in human papillomavirus 16 tumor growth. BMC Immunol 2010: 11: 27.
6. Dong DD, Yang H, Li K et al. Human leukocyte antigen-G (HLA-G) expression in cervical lesions: association with cancer progression, HPV 16/18 infection, and host immune response. Reprod Sci 2010: 17: 718-23.
7. Kovats S, Main EK, Librach C, Stubblebine M, Fisher SJ, DeMars R. A class I antigen, HLA-G, expressed in human trophoblasts. Science 1990: 248: 220-3.
8. Houlihan J, Biro P, Harper H, Jenkinson H, Holme C. The human amnion is a site of MHC class Ib expression: evidence for the expression of HLA-E and HLA-G. J Immunol 1995: 154: 5665-74.
9. Crisa L, McMaster MT, Ishii JK, Fisher SJ, Salomon DR. Identification of a thymic epithelial cell subset sharing expression of the class Ib HLA-G molecule with fetal trophoblasts. J Exp Med 1997: 186: 289-98.
10. Blaschitz A, Lenfant F, Mallet V et al. Endothelial cells in chorionic fetal vessels of first trimester placenta express HLA-G. Eur J Immunol 1997: 27: 3380-8.
11. Ishitani A, Geraghty D. Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens. Proc Natl Acad Sci U S A 1992: 89: 3947-51.
12. Hviid TV. HLA-G in human reproduction: aspects of genetics, function and pregnancy complications. Hum Reprod Update 2005: 12: 229-32.
13. Fournel S, Aguerre-Girr M, Huc X et al. Cutting edge: soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8. J Immunol 2000: 164: 6100-4.
14. Du L, Xiao X, Wang C et al. Human leukocyte antigen-G is closely associated with tumor immune escape in gastric cancer by increasing local regulatory T cells. Cancer Sci 2011: 102: 1272-80.
15. Marchal-Bras-Goncalves R, Rouas-Freiss N, Connan F et al. A soluble HLA-G protein that inhibits natural killer cell-mediated cytotoxicity. Transplant Proc 2001: 3: 2355-9.
16. Liang S, Ristich V, Arase H, Dausset J, Carosella ED, Horuzsko A. Modulation of dendritic cell differentiation by HLA-G and ILT4 requires the IL-6 - STAT3 signaling pathway. Proc Natl Acad Sci U S A 2008: 105: 8357-62.
17. Kapasi K, Albert SE, Yie S, Zavazava N, Librach CL. HLA-G has a concentration-dependent effect on the generation of an allo-CTL response. Immunology 2000: 101: 191-200.
18. LeMaoult J, Zafaranloo K, Le Danff C, Carosella ED. HLA-G up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells. FASEB J 2005: 19: 662-4.
19. Carosella ED. The telerogenic molecule HLA-G. Immunol Lett 2011: 138: 22-4.
20. Donadi EA, Castelli EC, Arnaiz-Villena A, Roger M, Rey D, Moreau P. Implications of the polymorphism of HLA-G on its function, regulation, evolution and disease association. Cell Mol Life Sci 2011: 68: 369-95.
21. Jiang Y, Chen S, Jia S et al. Association of HLA-G 3'UTR 14-bp insertion/deletion polymorphism with hepatocellular carcinoma susceptibility in a Chinese population. DNA Cell Biol 2011: 30: 1027-32.
22. Rizzo R, Bortolotti D, Fredj NB et al. Role of HLA-G 14bp deletion/insertion and +3142C>G polymorphisms in the production of sHLA-G molecules in relapsing-remitting multiple sclerosis. Hum Immunol 2012: 73: 1140-6.
23. Larsen MH, Zinyama R, Kallestrup P et al. HLA-G 3′ untranslated region 14-base pair deletion: association with poor survival in an HIV-1-infected Zimbabwean population. J Infect Dis 2013: 207: 903-6.
24. Teixeira AC, Mendes-Junior CT, Souza FF et al. The 14bp-deletion allele in the HLA-G gene confers susceptibility to the development of hepatocellular carcinoma in the Brazilian population. Tissue Antigens 2013: 81: 408-13.
25. Tan Z, Randall G, Fan J et al. Allele-specific targeting of microRNAs to HLA-G and risk of asthma. Am J Hum Genet 2007: 81: 829-34.
26. Consiglio CR, Veit TD, Monticielo OA et al. Association of the HLA-G gene +3142C>G polymorphism with systemic lupus erythematosus. Tissue Antigens 2011: 77: 540-5.
27. Cordero EA, Veit TD, da Silva MA, Jacques SM, Silla LM, Chies JA. HLA-G polymorphism influences the susceptibility to HCV infection in sickle cell disease patients. Tissue Antigens 2009: 74: 308-13.
28. Nicodemus-Johnson J, Laxman B, Stern RK et al. Maternal asthma and microRNA regulation of soluble HLA-G in the airway. J Allergy Clin Immunol 2013: 131: 1496-503.
29. Lucena-Silva N, Monteiro AR, de Albuquerque RS et al. Haplotype frequencies based on eight polymorphic sites at the 3′ untranslated region of the HLA-G gene in individuals from two different geographical regions of Brazil. Tissue Antigens 2012: 79: 272-8.
30. Hviid TV, Hylenius S, Rorbye C, Nielsen LG. HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels. Immunogenetics 2003: 55: 63-79.
31. Li XJ, Zhang X, Lin A, Ruan YY, Yan WH. Human leukocyte antigen-G (HLA-G) expression in cervical cancer lesions is associated with disease progression. Hum Immunol 2012: 73: 946-9.
32. Rodríguez JA, Galeano L, Palacios DM et al. Altered HLA class I and HLA-G expression is associated with IL-10 expression in patients with cervical cancer. Pathobiology 2012: 79: 72-83.
33. Yoon BS, Kim YT, Kim JW, Kim SH, Kim JH, Kim SW. Expression of human leukocyte antigen-G and its correlation with interleukin-10 expression in cervical carcinoma. Int J Gynaecol Obstet 2007: 98: 48-53.
34. Zheng N, Wang CX, Zhang X et al. Up-regulation of HLA-G expression in cervical premalignant and malignant lesions. Tissue Antigens 2011: 77: 218-24.
35. Guimarães MC, Soares CP, Donadi EA et al. Low expression of human histocompatibility soluble leukocyte antigen-G (HLA-G5) in invasive cervical cancer with and without metastasis, associated with papilloma virus (HPV). J Histochem Cytochem 2010: 58: 405-11.
36. Ferguson R, Ramanakumar AV, Koushik A, Coutlée F, Franco E, Roger M. Biomarkers of Cervical Cancer Risk Study Team. Human leukocyte antigen G polymorphism is associated with an increased risk of invasive cancer of the uterine cervix. Int J Cancer 2012: 131: E312-9.
37. Silva ID, Muniz YC, Sousa MC et al. HLA-G 3'UTR polymorphisms in high grade and invasive cervico-vaginal cancer. Hum Immunol 2013: 74: 452-8.
38. Simões RT, Gonçalves MA, Castelli EC et al. HLA-G polymorphisms in women with squamous intraepithelial lesions harboring human papillomavirus. Mod Pathol 2009: 22: 1075-82.
39. Rotola A, Costa S, Monini P et al. Impact of sexual habits on the clinical evaluation of male HPV infection. Eur J Epidemiol 1994: 10: 373-80.
40. Bortolotti D, Gentili V, Melchiorri L, Rotola A, Rizzo R. An accurate and reliable real time SNP genotyping assay for the HLA-G +3142 bp C>G polymorphism. Tissue Antigens 2012: 80: 259-62.
41. Djurisic S, Sørensen AE, Hviid TV. A fast and easy real-time PCR genotyping method for the HLA-G 14-bp insertion/deletion polymorphism in the 3′ untranslated region. Tissue Antigens 2012: 79: 186-9.
42. Brown DR, Schroeder JM, Bryan JT, Stoler MH, Fife KH. Detection of multiple human papillomavirus types in condylomata acuminata lesions from otherwise healthy and immunosuppressed patients. J Clin Microbiol 1999: 37: 3316-22.
43. Clifford GM, Rana RK, Franceschi S, Smith JS, Gough G, Pimenta JM. Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer. Cancer Epidemiol Biomarkers Prev 2005: 14: 1157-64.
44. Clerici M, Merola M, Ferrario E et al. Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection. J Natl Cancer Inst 1997: 89: 245-50.